CTOR vs EL · $105.2M cap vs rev $15.05B
Citius Oncology, Inc. (CTOR) versus Estee Lauder Companies Inc (EL) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Estee Lauder Companies Inc (EL) is a household & personal products company listed on US.
CTOR does not have a complete income-statement cache yet.
Latest reported EL revenue for 2026-06-30 was $15.05B. Net income was $182.0M. Revenue was up 5.0% from 2025-06-30 to 2026-06-30. EL currently screens at market cap $31.92B.
CTOR currently screens at market cap $105.2M. EL currently screens at market cap $31.92B.
Not investment advice. Open the CTOR and EL stock pages for the full models.
Not investment advice.